UNICREDIT BANK/CALL/ROCHE GS/280/0.1/18.12.24 Share Price

Warrant

DE000HC8HBW8

Real-time Bid/Ask 12:01:37 03/07/2024 pm IST
0.42 EUR / 0.48 EUR +12.50% Intraday chart for UNICREDIT BANK/CALL/ROCHE GS/280/0.1/18.12.24
Current month-9.09%
1 month+48.15%
Date Price Change
03/24/03 0.4 0.00%
01/24/01 0.4 -9.09%
28/24/28 0.44 -4.35%
27/24/27 0.46 +4.55%
26/24/26 0.44 -21.43%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 12:24 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer UniCredit UniCredit
WKN HC8HBW
ISINDE000HC8HBW8
Date issued 07/08/2023
Strike 280 CHF
Maturity 18/12/2024 (169 Days)
Parity 10 : 1
Emission price 1.62
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.7
Lowest since issue 0.1
Delta0.23x
Omega 13.12
Premium14.44x
Gearing56.74x
Moneyness 0.8875
Difference Strike 32.3 CHF
Difference Strike %+11.54%
Spread 0.06
Spread %12.50%
Theoretical value 0.4500
Implied Volatility 20.65 %
Total Loss Probability 80.93 %
Intrinsic value 0.000000
Present value 0.4500
Break even 284.38 €
Theta-0.02x
Vega0.05x
Rho0.03x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
248.5 CHF
Average target price
278.3 CHF
Spread / Average Target
+11.98%
Consensus